Transducin β-like protein 1 recruits nuclear factor κB to the target gene promoter for transcriptional activation

Molecular and Cellular Biology

Volumn 31, Issue 5, 2011, Pages 924-934

  Ramadoss, Sivakumar ^a   Li, Jiong ^a   Ding, Xiangming ^a   Al Hezaimi, Khalid ^b   Wang, Cun Yu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSDUCIN; TRANSDUCIN BETA LIKE PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER TISSUE; CONTROLLED STUDY; GENE; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

ADENOCARCINOMA; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSDUCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952268280     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00576-10     Document Type: Article

References (52)

1. Baek, S. H., et al. 2002. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and beta-amyloid precursor protein. Cell 110:55-67. (Pubitemid 34874606)
2. Baldwin, A. S. 2001. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J. Clin. Invest. 107:241-246.
3. Burstein, E., et al. 2005. COMMD proteins, a novel family of structural and functional homologs of MURR1. J. Biol. Chem. 280:22222-22232.
4. Chen, L. F., W. Fischle, E. Verdin, and W. C. Greene. 2000. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293:1653-1657.
5. de Bie, P., et al. 2006. Characterization of COMMD protein-protein interactions in NF-κB signalling. Biochem. J. 398:63-71.
6. Dimitrova, Y. N., et al. 2010. Direct ubiquitination of beta-catenin by Siah-1 and regulation by the exchange factor TBL1. J. Biol. Chem. 285:13507-13516.
7. Espinosa, L., J. Inglés-Esteve, A. Robert-Moreno, and A. Bigas. 2003. IκBα and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFκB pathways. Mol. Biol. Cell 14:491-502.
8. Gao, Z., et al. 2005. Coactivators and corepressors of NF-κB in IκB alpha gene promoter. J. Biol. Chem. 280:21091-21098.
9. Garg, A., and B. B. Aggarwal. 2002. Nuclear transcription factor-κB as a target for cancer drug development. Leukemia 16:1053-1068.
10. Geng, H., T. Wittwer, O. Dittrich-Breiholz, M. Kracht, and M. L. Schmitz. 2009. Phosphorylation of NF-κB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep. 10:381-386.
11. Guenther, M. G., O. Barak, and M. A. Lazar. 2001. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21:6091-6101.
12. Guenther, M. G., et al. 2000. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 14:1048-1057. (Pubitemid 30324419)
13. Helbig, G., et al. 2003. NF-κB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 278:21631-21638.
14. Hermanson, O., K. Jepsen, and M. G. Rosenfeld. 2002. N-CoR controls differentiation of neural stem cells into astrocytes. Nature 419:934-939.
15. Hoberg, J. E., F. Yeung, and M. W. Mayo. 2004. SMRT derepression by the IκB kinase alpha: a prerequisite to NF-κB transcription and survival. Mol. Cell 16:245-255.
16. Hong, S. H., and M. L. Privalsky. 2000. The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol. Cell. Biol. 20:6612-6625.
17. Hu, M. C., et al. 2004. IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117:225-237. (Pubitemid 38496242)
18. Huber, M. A., et al. 2004. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114:569-581.
19. Ito, K., P. J. Barnes, and I. M. Adcock. 2000. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20:6891-6903.
20. Ito, K., E. Jazrawi, B. Cosio, P. J. Barnes, and I. M. Adcock. 2001. p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J. Biol. Chem. 276:30208-30215.
21. 2+/calmodulin-dependent protein kinase IV stimulates nuclear factor-kappa B transactivation via phosphorylation of the p65 subunit. J. Biol. Chem. 276:20005-20010.
22. Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2:301-310.
23. Kiernan, R., et al. 2003. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278:2758-2766.
24. Lee, S. K., J. H. Kim, Y. C. Lee, J. Cheong, and J. W. Lee. 2000. Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-κB, and serum response factor. J. Biol. Chem. 275:12470-12474.
25. Li, J., and C. Y. Wang. 2008. TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis. Nat. Cell Biol. 10:160-169.
26. Li, J., et al. 2000. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 9:4342-4350. (Pubitemid 30623745)
27. Maine, G. N., X. Mao, C. M. Komarck, and E. Burstein. 2007. COMMD1 promotes the ubiquitination of NF-κB subunits through a cullin-containing ubiquitin ligase. EMBO J. 26:436-447. (Pubitemid 46160944)
28. Matsuzawa, S. I., and J. C. Reed. 2001. Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol. Cell 7:915-926.
29. Mayo, M. W., et al. 2003. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J. Biol. Chem. 278:18980-18989.
30. Merkhofer, E. C., P. Cogswell, and A. S. Baldwin. 2010. Her2 activates NF-κB and induces invasion through the canonical pathway involving IKKα. Oncogene 29:1238-1248.
31. Nakshatri, H., P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet, and G. W. Sledge. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629-3639.
32. Pahl, H. L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18:6853-6866.
33. Park, B. K., et al. 2007. NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat. Med. 13:62-69.
34. Pereira, S. G., and L. Oakley. 2008. Nuclear factor-κB1: regulation and function. Int. J. Biochem. Cell Biol. 40:1425-1430.
35. Perissi, V., A. Aggarwal, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526.
36. Perissi, V., et al. 2008. TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Mol. Cell 29:755-766. (Pubitemid 351400927)
37. Perkins, N. D. 2004. Regulation of NF-κB by atypical activators and tumour suppressors. Biochem. Soc. Trans. 32:936-939.
38. Pratilas, C. A., et al. 2009. BRAF (V600E) is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway. Proc. Natl. Acad. Sci. U. S. A. 106:4519-4524.
39. Radvanyi, L., et al. 2005. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 102:11005-11010.
40. Richardson, A. L., et al. 2006. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9:121-132. (Pubitemid 43202662)
41. Sovak, M. A., et al. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:2952-2960.
42. Tomita, A., D. R. Buchholz, and Y. B. Shi. 2004. Recruitment of N-CoR/SMRTTBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development. Mol. Cell. Biol. 24:3337-3346.
43. Tomita, A., D. R. Buchholz, K. Obata, and Y. B. Shi. 2003. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo. J. Biol. Chem. 278:30788-30795.
44. Vermeulen, K., Z. N. Berneman, and D. R. Van Bockstaele. 2003. Cell cycle and apoptosis. Cell Prolif. 36:165-175.
45. Wang, C.-Y., M. Mayo, and A. S. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis potentiation by inhibition of NF-κB. Science 274:784-787.
46. Wang, C.-Y., M. W. Mayo, R. C. Korneluk, D. V. Goeddel, and A. S. Baldwin. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
47. Wang, C.-Y., D. C. Guttridge, M. W. Mayo, and A. S. Baldwin. 1999. NF-κB expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 19:5923-5929.
48. Wang, C.-Y., J. Cusack, R. Liu, and A. S. Baldwin. 1999. Control of inducible chemoresistance: enhanced anti-tumor therapy via increased apoptosis through inhibition of NF-κB. Nat. Med. 5:412-417.
49. Yoon, H. G., et al. 2003. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22:1336-1346.
50. Zhang, J., M. G. Guenther, R. W. Carthew, and M. A. Lazar. 1998. Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev. 12:1775-1780.
51. Zhang, J., M. Kalkum, B. T. Chait, and R. G. Roeder. 2002. The N-CoRHDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9:611-623.
52. Zhou, Y., W. Gross, S. H. Hong, and M. L. Privalsky. 2001. The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II). Mol. Cell. Biochem. 220:1-13.